ETH-LAD
N⁶-ethyl-6-norlysergic acid diethylamide
1Provenance card
the boundary, as counts
Sources
1917 with DOI
5 strong · 13 moderate · 1 weak
Compilations
12026-04-26T10:39:30.249Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
31last ruled 2026-06-04
0 awaiting a ruling
Issued documents
62026-10-19T20:31:52.032Z
notice · info card · emergency
Searches
243 with no results
queries and counts on the build
Claims checked
6545 supported
45 supported · 20 not
Correspondence
0received
consent field ships in Phase 4
Edges
221
derivations recorded for this entity
Complete over 19 sources, 1 compilation, and 31 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/eth-lad/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued emergency
- 2026-10-19issueIssued info_card
- 2026-10-19issueIssued notice
- 2026-09-24srcReturn of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)
- 2026-09-24srcReturn of the lysergamides. Part II: Analytical and behavioural characterization of N6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ)
- 2026-09-24srcReturn of the lysergamides. Part III: Analytical characterization of ETH-LAD and 1P-ETH-LAD
- 2026-09-24srcReturn of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD)
- 2026-09-24srcAnalytical and behavioral characterization of N-ethyl-N-isopropyllysergamide (EIPLA), an isomer of ETH-LAD
- 2026-09-24srcGenie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile
- 2026-09-24srcIn vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures
- 2026-09-24srcCrystal Structure of an LSD-Bound Human Serotonin Receptor
- 2026-09-24srcPharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD)
- 2026-09-24src5-HT2A receptors: Pharmacology and functional selectivity
- 2026-09-24srcTolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice
- 2026-09-24srcSynthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives
- 2026-09-24srcModern Clinical Research on LSD
- 2026-09-24srcAcute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
- 2026-09-24srcDirect comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
- 2026-09-24srcPsychedelics
- 2026-09-24srcREBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
- 2026-09-24srcStudies on lysergic acid diethylamide and related compounds. IV. Syntheses of various amide derivatives of norlysergic acid and related compounds
- 2026-09-24srcTiHKAL: The Continuation - Entry #12: ETH-LAD
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-06-04proposal29 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-04-26revisionRevision 1
- 2026-04-26absenceSearched PubMed for "psychedelic contraindication personal history psychosis bipolar disorder risk" — no results
- 2026-04-26absenceSearched ClinicalTrials.gov for "ETH-LAD lysergamide" — no results
- 2026-04-26absenceSearched ClinicalTrials.gov for "ETH-LAD lysergamide" — no results
- 2026-04-26genGeneration — pipeline-v5pipeline-v5
- 2026-04-26rungeneration run
The same entries, as forms: six forms.